Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live‐Cell Imaging Platform
Cytometry Part A · 2025
DOI: 10.1002/cyto.a.24930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, 2025. Verfasst von Roser Salvia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Functional Cytomics Lab, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona (UAB), Badalona, Spain. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lung Neoplasms, Cytotoxicity, Immunologic. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Sartorius, Thermo Fisher Scientific, Centres de Recerca de Catalunya.
Abstract (Originalsprache)
Cellular cytotoxicity is an important mechanism of the immune system to clear infections and eliminate tumor cells. Its two main mediators are cytotoxic T lymphocytes and natural killer (NK) cells. In lung cancer, intratumoral NK cells show reduced cytolytic potential and one third of patients do not express HLA‐I proteins, which activate NK cells in a process termed “absent self‐recognition.” In this work, we investigate NK cytotoxicity as a potential oncological biomarker that informs patient status and predicts response to treatment. We describe a simple and rapid test to analyze NK cytotoxicity without the need for large volumes of blood, requiring short processing time and reduced use of both reagents and blood samples, using the IncuCyte live imaging technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Functional Cytomics Lab, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona (UAB), Badalona, Spain.
- Medical Oncology Department, Catalan Institute of Oncology Badalona (ICO), Germans Trias i Pujol University Hospital (HUGTiP), Badalona, Spain.
- Applied Research Group in Oncology, Germans Trias i Pujol Research Institute (IGTP) Badalona, Barcelona, Spain.
- Department of Medicine, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
- Sartorius Stedim North America, Inc., Arvada, Colorado, USA.
- Thermo Fisher Scientific, Fort Collins, Colorado, USA.
ORCID-Profile: Jordi Petriz
Förderung
- Sartorius
- Thermo Fisher Scientific
- Centres de Recerca de Catalunya
- 'la Caixa' Foundation
- Agència de Gestió d'Ajuts Universitaris i de Recerca
Zitieren
APA
Salvia, R., Rico, L. G., Morán, T., Olszowy, M. W., Ward, M. D., & Petriz, J. (2025). Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live‐Cell Imaging Platform. Cytometry Part A. https://doi.org/10.1002/cyto.a.24930
Vancouver
Salvia R, Rico LG, Morán T, Olszowy MW, Ward MD, Petriz J. Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live‐Cell Imaging Platform. Cytometry Part A. 2025. doi:10.1002/cyto.a.24930
BibTeX
@article{Salvia2025,
author = {Salvia, Roser and Rico, Laura G and Morán, Teresa and Olszowy, Michael W and Ward, Michael D and Petriz, Jordi},
title = {Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live‐Cell Imaging Platform},
journal = {Cytometry Part A},
year = {2025},
doi = {10.1002/cyto.a.24930}
}
EUVIMED